Virax Holdings Limited
is a Public company. Wayne A Millen is the CEO of Virax Holdings Limited and has an approval rating of 69 from Owler members. Virax Holdings Limited's most recent acquisition was Pathway Oncology Pty Ltd. for an undisclosed amount on Mar 2014. Virax Holdings Limited has 1 followers on Owler.Virax Holdings Limited
is a Public company. Wayne A Millen is the CEO of Virax Holdings Limited and has an approval rating of 69 from Owler members. Virax Holdings Limited's most recent acquisition was Pathway Oncology Pty Ltd. for an undisclosed amount on Mar 2014. Virax Holdings Limited has 1 followers on Owler.
CEO
Wayne A Millen
News
Dec 01, 2014
PROACTIVE INVESTORS
Virax: Virax Holdings changes name to Prescient Therapeutics
Nov 11, 2014
PROACTIVE INVESTORS
Virax: Mirvac Group, Virax Holdings and Deep Yellow among Tuesday's ASX Volume leaders
Oct 17, 2014
BIOSPACE
Virax: <b>Virax</b> To Acquire Deep AKT Inhibitor Portfolio Already In Phase 1b/2 Breast & Phase 1b Ovarian Cancer Trials
Oct 15, 2014
PROACTIVE INVESTORS
Virax: Virax Holdings to make material transaction
May 05, 2014
PROACTIVE INVESTORS
Virax: Virax Holdings options global license for cancer treatment screening
May 01, 2014
PROACTIVE INVESTORS
Virax: Virax Holdings in pre-open, to reveal a 'material transaction'
Apr 24, 2014
PROACTIVE INVESTORS
Virax: Virax Holdings advances new prospects for Co-X-Gene anti-cancer technology
Feb 19, 2014
PROACTIVE INVESTORS
Virax: Virax Holdings to focus on Co-X-Gene cancer treatment, attracts interest from Sanofi
Feb 07, 2014
PROACTIVE INVESTORS
Virax: Virax Holdings' lung cancer drug gives positive results for licensee Trangene